article thumbnail

Teva asks SCOTUS to overturn “skinny label” verdict on GSK drug

pharmaphorum

Things became litigious in 2017, when a Delaware court found that Teva’s label for its generic encouraged doctors to use the drug to treat heart failure in a way that infringed GSK’s RE40,000 patent, which was reissued by the Patent and Trademark Office (PTO) in 2008.

article thumbnail

Beating the Big C

Pharmaceutical Technology

The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. “And there’s a tremendous opportunity to meet their needs.” So what’s driving the growth? There’s been a huge change in the market.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Witty Answer to GSK’s Future

Pharmaceutical Technology

Andrew Witty took the helm of pharmaceutical giant GlaxoSmithKline in May 2008. PT: Given recent problems with a safety scare over diabetes drug Avandia and GSK’s guidance for a fall in 2008 earnings, what do you envisage Witty’s top or first priorities will be in the new job?

article thumbnail

Q&A: Cleaning up the antibiotic resistance problem in dentistry

Pharmaceutical Technology

Dentists are responsible for 5-10% of antibiotic prescriptions worldwide , and thus a significant part of the overall global crisis. So often the Friday prescription is given so by the time a patient comes on Monday, they think the pain is under control, and can be given an injection. This reduced prescriptions a lot.